Market Cap 7.31M
Revenue (ttm) 0.00
Net Income (ttm) -4.51M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 123,500
Avg Vol 100,756
Day's Range N/A - N/A
Shares Out 3.81M
Stochastic %K 19%
Beta -0.25
Analysts Sell
Price Target $28.00

Company Profile

Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-pe...

Industry: Biotechnology
Sector: Healthcare
Phone: 844 722 6333
Address:
3480 Peachtree Road NE, Second Floor, Suite 103, Atlanta, United States
hiwatt
hiwatt Mar. 21 at 7:40 PM
$ALZN Key Comparisons: Type & Status: Lithium orotate is a dietary supplement, whereas AL001 is a drug candidate in clinical trials. Efficacy & Potency: AL001 is engineered to deliver higher lithium concentrations to the brain at lower total doses compared to conventional lithium. Preclinical studies show AL001 superior in improving memory and reducing irritability compared to other lithium forms. Safety Profile: Both aim to reduce the high-toxicity risks (kidney/thyroid issues) of conventional prescription lithium carbonate, which has a narrow therapeutic index. Mechanism: Lithium orotate is thought to be more bioavailable than lithium carbonate, while AL001 is a novel, patented delivery system (ionic cocrystal) designed to maximize brain delivery.
0 · Reply
hiwatt
hiwatt Mar. 21 at 7:18 PM
$ALZN Lithium orotate made all the national news outlets when the Harvard poster child presented study results. I wonder if the redheaded step child, Alzamend Nuero will get the same coverage when they present topline data in the next 7 trading days?--- Lithium orotate is an over-the-counter dietary supplement used for low-dose, general cognitive support. Conversely, AL001 (LiProSal) is an investigational, patented lithium-salicylate-L-proline ionic cocrystal designed as a high-penetrance, low-toxicity pharmaceutical for Alzheimer's and neurodegeneration, promising higher brain delivery and safer,, targeted, and more effective treatment than traditional lithium salts.
0 · Reply
SinglesOverHomeRun
SinglesOverHomeRun Mar. 20 at 10:47 PM
$ALZN oh yeaaa Meg! 🥒PT $ALLTHEWAY
0 · Reply
NolAsrtormZ
NolAsrtormZ Mar. 20 at 10:24 PM
$ALZN $300 million market cap $60 a share You get the idea
0 · Reply
NolAsrtormZ
NolAsrtormZ Mar. 20 at 10:23 PM
$ALZN 200 million market cap $40 a share
0 · Reply
NolAsrtormZ
NolAsrtormZ Mar. 20 at 10:23 PM
$ALZN 100 million market cap $20 a share
0 · Reply
NolAsrtormZ
NolAsrtormZ Mar. 20 at 10:22 PM
$ALZN nothing 2 see here.... 100's or billions in market cap No wonder they are looking 4 stops
0 · Reply
NolAsrtormZ
NolAsrtormZ Mar. 20 at 8:57 PM
$ALZN lololololol, Has until May. Has until September. $100 a share still in play. Alzheimers data is gold
0 · Reply
SinglesOverHomeRun
SinglesOverHomeRun Mar. 20 at 8:51 PM
$ALZN delisting notice just filed from Nasdaq but don't worry, we got this. If not, we will reverse split and start again. Our loyal retail buyers will support us. $575 PT for next week!!!!!
0 · Reply
NolAsrtormZ
NolAsrtormZ Mar. 20 at 8:26 PM
$ALZN what is a dragon fly dogi
0 · Reply
Latest News on ALZN
Alzamend Neuro Announces Reverse Stock Split

May 8, 2025, 8:00 AM EDT - 11 months ago

Alzamend Neuro Announces Reverse Stock Split


See Why Alzamend Neuro Stock Is Rallying On Thursday

Sep 30, 2021, 1:45 PM EDT - 4 years ago

See Why Alzamend Neuro Stock Is Rallying On Thursday


Why Alzamend Neuro Shares Are Surging Higher Today

Sep 30, 2021, 11:54 AM EDT - 4 years ago

Why Alzamend Neuro Shares Are Surging Higher Today


Alzamend Neuro, Inc. to Ring Nasdaq Opening Bell Today

Jul 12, 2021, 6:00 AM EDT - 5 years ago

Alzamend Neuro, Inc. to Ring Nasdaq Opening Bell Today


Alzamend Neuro Announces Pricing of Initial Public Offering

Jun 14, 2021, 5:49 PM EDT - 5 years ago

Alzamend Neuro Announces Pricing of Initial Public Offering


hiwatt
hiwatt Mar. 21 at 7:40 PM
$ALZN Key Comparisons: Type & Status: Lithium orotate is a dietary supplement, whereas AL001 is a drug candidate in clinical trials. Efficacy & Potency: AL001 is engineered to deliver higher lithium concentrations to the brain at lower total doses compared to conventional lithium. Preclinical studies show AL001 superior in improving memory and reducing irritability compared to other lithium forms. Safety Profile: Both aim to reduce the high-toxicity risks (kidney/thyroid issues) of conventional prescription lithium carbonate, which has a narrow therapeutic index. Mechanism: Lithium orotate is thought to be more bioavailable than lithium carbonate, while AL001 is a novel, patented delivery system (ionic cocrystal) designed to maximize brain delivery.
0 · Reply
hiwatt
hiwatt Mar. 21 at 7:18 PM
$ALZN Lithium orotate made all the national news outlets when the Harvard poster child presented study results. I wonder if the redheaded step child, Alzamend Nuero will get the same coverage when they present topline data in the next 7 trading days?--- Lithium orotate is an over-the-counter dietary supplement used for low-dose, general cognitive support. Conversely, AL001 (LiProSal) is an investigational, patented lithium-salicylate-L-proline ionic cocrystal designed as a high-penetrance, low-toxicity pharmaceutical for Alzheimer's and neurodegeneration, promising higher brain delivery and safer,, targeted, and more effective treatment than traditional lithium salts.
0 · Reply
SinglesOverHomeRun
SinglesOverHomeRun Mar. 20 at 10:47 PM
$ALZN oh yeaaa Meg! 🥒PT $ALLTHEWAY
0 · Reply
NolAsrtormZ
NolAsrtormZ Mar. 20 at 10:24 PM
$ALZN $300 million market cap $60 a share You get the idea
0 · Reply
NolAsrtormZ
NolAsrtormZ Mar. 20 at 10:23 PM
$ALZN 200 million market cap $40 a share
0 · Reply
NolAsrtormZ
NolAsrtormZ Mar. 20 at 10:23 PM
$ALZN 100 million market cap $20 a share
0 · Reply
NolAsrtormZ
NolAsrtormZ Mar. 20 at 10:22 PM
$ALZN nothing 2 see here.... 100's or billions in market cap No wonder they are looking 4 stops
0 · Reply
NolAsrtormZ
NolAsrtormZ Mar. 20 at 8:57 PM
$ALZN lololololol, Has until May. Has until September. $100 a share still in play. Alzheimers data is gold
0 · Reply
SinglesOverHomeRun
SinglesOverHomeRun Mar. 20 at 8:51 PM
$ALZN delisting notice just filed from Nasdaq but don't worry, we got this. If not, we will reverse split and start again. Our loyal retail buyers will support us. $575 PT for next week!!!!!
0 · Reply
NolAsrtormZ
NolAsrtormZ Mar. 20 at 8:26 PM
$ALZN what is a dragon fly dogi
0 · Reply
SinglesOverHomeRun
SinglesOverHomeRun Mar. 20 at 8:25 PM
$ALZN yum! PT $400
0 · Reply
SinglesOverHomeRun
SinglesOverHomeRun Mar. 20 at 8:23 PM
$ALZN woooops ...wrong button. thats better
0 · Reply
SinglesOverHomeRun
SinglesOverHomeRun Mar. 20 at 8:22 PM
$ALZN $300 a share! lets goooooo
0 · Reply
NolAsrtormZ
NolAsrtormZ Mar. 20 at 7:53 PM
$ALZN the share float is soooo, small thats why the share price will moon
0 · Reply
NolAsrtormZ
NolAsrtormZ Mar. 20 at 7:52 PM
$ALZN $100 a share Data🤣
0 · Reply
NolAsrtormZ
NolAsrtormZ Mar. 20 at 7:52 PM
$ALZN all you have to do is look back when anvs, biib, sava released their phase 2 Alzheimers data to get expected price movement
0 · Reply
SinglesOverHomeRun
SinglesOverHomeRun Mar. 20 at 7:44 PM
$ALZN $250 per share! who can raise me???🤪
0 · Reply
NolAsrtormZ
NolAsrtormZ Mar. 20 at 7:21 PM
$ALZN $100 a share is 500 million market cap Market cap is only 7 million
0 · Reply
NolAsrtormZ
NolAsrtormZ Mar. 20 at 7:19 PM
$ALZN similar share float to anvs when they released Alzheimers Data got to $100
0 · Reply
NolAsrtormZ
NolAsrtormZ Mar. 20 at 7:18 PM
$ALZN history repeats itself. Alzheimers data is worth Billion in market cap. Refer to biib Refer to sava Refer to anvs Billion $$$ jumps n market cap after Alzheimers data release
0 · Reply
SinglesOverHomeRun
SinglesOverHomeRun Mar. 20 at 7:15 PM
$ALZN wrong! this is passing the S&P 500 itself. Buy more....sh!t has never been more attractive. we all love a good load of crap💩 Im very bullish
0 · Reply
MindfulMonkey
MindfulMonkey Mar. 20 at 7:08 PM
$ALZN share value being lowered to reduce share premiums in the event of an acquisition after positive results? 🤫🤫
0 · Reply